LOXIMRA Trademark

Trademark Overview


On Friday, March 14, 2008, a trademark application was filed for LOXIMRA with the United States Patent and Trademark Office. The USPTO has given the LOXIMRA trademark a serial number of 77422365. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 1, 2016. This trademark is owned by AstraZeneca AB. The LOXIMRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the fields of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases
loximra

General Information


Serial Number77422365
Word MarkLOXIMRA
Filing DateFriday, March 14, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 1, 2016
Registration Number3671587
Registration DateTuesday, August 25, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 9, 2009

Trademark Statements


Goods and ServicesPharmaceutical preparations in the fields of oncology, cardiovascular diseases, respiratory diseases, inflammation/infection, gastrointestinal diseases and central nervous system diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events


Event DateEvent Description
Friday, April 1, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, August 25, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, June 9, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 20, 2009NOTICE OF PUBLICATION
Thursday, May 7, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 5, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, November 18, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, November 18, 2008INQUIRY TO SUSPENSION E-MAILED
Tuesday, November 18, 2008SUSPENSION INQUIRY WRITTEN
Saturday, November 1, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 1, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 1, 2008LETTER OF SUSPENSION E-MAILED
Thursday, May 1, 2008SUSPENSION LETTER WRITTEN
Thursday, May 1, 2008ASSIGNED TO EXAMINER
Thursday, April 3, 2008PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM